VBI Vaccines announces proposed public offering of common shares
VBI Vaccines announced it has commenced an underwritten public offering of its common shares. VBI also intends to grant underwriters a 30-day option to purchase up to an additional 15% of the number of common shares offered in the public offering. December 12, 2018